Buddleja saligna Willd chelates iron, inhibits angiotensin-converting enzyme, acetylcholinesterase, and lipase, and modulates serum lipids and metabolic pathways in vitro.
Buddleja saligna Willd (Loganiaceae) inhibits angiotensin-converting enzyme activity in oxidative cardiopathy with concomitant modulation of nucleotide hydrolyzing enzymatic activities and dysregulated lipid metabolic pathways.
AI Summary
Key Findings
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: Buddleja saligna Willd (Loganiaceae), mostly indigenous to South Africa is traditionally used in the treatment cardio-dysfunctional related ailments amongst other diseases. AIMS: The cardio-protective effect of B. saligna was investigated in ferric-induced oxidative cardiopathy. METHODS: Hearts harvested from healthy male SD rats were incubated with 0.1 mM FeSOto induce oxidative damage and co-incubated with B. saligna extract. Reaction mixtures without the extract served as negative control, while tissues without the extract or standard antioxidant (gallic acid) and pro-oxidant served as the normal control. The tissues were analyzed for levels of glutathione, malondialdehyde, and nitric oxide as well as cholinergic, angiotensin-converting enzyme (ACE), lipase, and purinergic enzymes activities, lipid profiles, fatty acid metabolic pathways and metabolites. RESULTS: Induction of oxidative damage significantly (p
Affiliation
Ochuko L Erukainure
External References
- PubMed ID:
- 31676404
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.